Extracellular cyclophilin A protects against blast-induced neuronal injury

Neurosci Res. 2013 May-Jun;76(1-2):98-100. doi: 10.1016/j.neures.2013.02.009. Epub 2013 Mar 17.

Abstract

Blast-induced traumatic brain injury (TBI) and subsequent neurobehavioral deficits are major disabilities suffered by the military and civilian population worldwide. Rigorous scientific research is underway to understand the mechanism of blast TBI and thereby develop effective therapies for protection and treatment. By using an in vitro shock tube model of blast TBI with SH-SY5Y human neuroblastoma cells, we have demonstrated that blast exposure leads to neurobiological changes in an overpressure and time dependent manner. Paradoxically, repeated blast exposures resulted in less neuronal injury compared to single blast exposure and suggested a potential neuroprotective mechanism involving released cyclophilin A (CPA). In the present study, we demonstrate accumulation of CPA in the culture medium after repeated blast exposures supporting the notion of extracellular CPA mediated neuroprotection. Post-exposure treatment of the cells with purified recombinant CPA caused significant protection against blast-induced neuronal injury. Furthermore, repeated blast exposure was associated with phosphorylation of the proteins ERK1/2 and Bad suggesting a potential mechanism of neuroprotection by extracellular CPA and may aid in the development of targeted therapies for protection against blast-induced TBI.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blast Injuries / metabolism*
  • Blast Injuries / pathology
  • Blotting, Western
  • Brain Injuries / metabolism*
  • Brain Injuries / pathology
  • Cell Line
  • Cyclophilin A / metabolism*
  • Cyclophilin A / pharmacology
  • Humans
  • Neurons / metabolism*
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology

Substances

  • Neuroprotective Agents
  • Cyclophilin A